I now have comprehensive content. Let me compile the full explanation.
Mechanism of Acute Respiratory Distress Syndrome (ARDS)
Definition and Core Concept
ARDS is a form of noncardiogenic pulmonary edema characterized by diffuse alveolar damage (DAD), refractory hypoxemia, and severely reduced lung compliance. Unlike cardiogenic pulmonary edema (which is hydrostatic), ARDS edema is exudative — the alveolar-capillary barrier becomes pathologically permeable, allowing protein-rich fluid to flood the airspaces. — Murray & Nadel's Textbook of Respiratory Medicine
Triggers: Direct vs. Indirect Lung Injury
| Direct (Pulmonary) | Indirect (Non-pulmonary) |
|---|
| Pneumonia (bacterial, viral, COVID-19) | Sepsis |
| Aspiration of gastric contents | Major trauma |
| Pulmonary contusion | Multiple blood transfusions |
| Toxic inhalation / near-drowning | Pancreatitis |
| Reperfusion injury (post-transplant) | Drug overdose / cardiopulmonary bypass |
The highest-risk triggers are sepsis, major trauma, aspiration, and massive transfusion. Having multiple risk factors additively increases ARDS incidence. — Murray & Nadel's
Phases of Pathology (Diffuse Alveolar Damage)
ARDS proceeds through three overlapping stages:
1. Exudative phase (0–7 days)
- Hyaline membrane formation (cellular debris + proteins + surfactant components)
- Protein-rich fluid fills alveolar spaces
- Widespread epithelial disruption
- Massive neutrophil infiltration of interstitium and airspaces
2. Proliferative phase (days 7–21)
- Hyaline membranes are reorganized
- Fibrosis begins to appear
- Pulmonary capillary obliteration
- Interstitial and alveolar collagen deposition
- Neutrophil numbers decrease
3. Fibrotic phase (>2 weeks in persistent ARDS)
- Frank pulmonary fibrosis in a subset of patients
- Elevated N-terminal procollagen peptide III detectable in BAL fluid as early as 24 hours — indicating that fibroproliferation may begin simultaneously with, rather than after, the inflammatory injury
The Alveolar-Capillary Barrier: Core Mechanism
The alveolar-capillary barrier has two components:
Pulmonary microvascular endothelium
- Normally, the endothelium is a semi-permeable barrier, but under inflammatory conditions it becomes highly permeable
- Neutrophil-derived oxidants, proteases, and cytokines directly injure endothelial cells
- Loss of endothelial integrity → protein-rich edema fluid leaks into the interstitium and alveoli
Alveolar epithelium (Type I and Type II pneumocytes)
- Type I cells (covering ~95% of the alveolar surface) are exquisitely sensitive to injury; their death causes massive permeability failure
- Type II cells (normally 5% of surface) are more resilient; they are responsible for surfactant production and for regenerating Type I cells during repair
- In ARDS, Type II cell dysfunction leads to surfactant deficiency, causing alveolar collapse and worsening shunt
- Normally, Type II cells reabsorb alveolar fluid via active sodium transport (ENaC channels); in ARDS this fluid-clearance capacity is severely impaired
Neutrophil-Mediated Injury: The Central Effector
Neutrophil activation and sequestration in the pulmonary microvasculature is the central mechanism of alveolar injury:
- An initiating stimulus (e.g., LPS from gram-negative bacteria in sepsis, gastric acid in aspiration) activates alveolar macrophages
- Activated macrophages release IL-1β, IL-6, IL-8 (CXCL8), and TNF-α
- IL-8 is a potent neutrophil chemoattractant — it recruits circulating neutrophils to the lung
- Neutrophils marginate against pulmonary capillary endothelium via upregulated adhesion molecules (E-selectin, ICAM-1)
- Transmigrated neutrophils release:
- Reactive oxygen species (ROS) — oxidize lipid membranes, DNA, and proteins
- Proteases (elastase, matrix metalloproteinases) — degrade the extracellular matrix and tight junctions
- Platelet-activating factor and leukotrienes — amplify the inflammatory response
- This causes widespread alveolar epithelial and endothelial death → barrier failure
Coagulation and Vascular Mechanisms
- Intravascular fibrin deposition in pulmonary capillaries causes microvascular obstruction
- Fibrin is also deposited in alveolar spaces, contributing to hyaline membrane formation
- Activated neutrophils and platelets further promote a prothrombotic, anti-fibrinolytic state in the lung
- These vascular changes contribute to pulmonary hypertension, alongside hypoxic vasoconstriction and mechanical compression of vessels by positive-pressure ventilation
Surfactant Dysfunction
- Phospholipase A2 (released systemically in pancreatitis, and locally in other triggers) enzymatically degrades surfactant
- Protein-rich edema fluid in alveoli also directly inactivates surfactant
- Loss of surfactant increases surface tension, causing alveolar collapse, reduced compliance, and worsening intrapulmonary shunt
Physiological Consequences
| Mechanism | Physiological Effect |
|---|
| Alveolar flooding + collapse | ↓ FRC, ↓ lung compliance |
| Right-to-left shunting through flooded alveoli | Refractory hypoxemia (PaO₂/FiO₂ < 300 mmHg) |
| Dead space ventilation | Hypercapnia despite high minute ventilation |
| Microvascular obstruction + hypoxic vasoconstriction | Pulmonary hypertension → RV strain |
| Surfactant loss | Further alveolar instability and collapse |
Dead space is significantly increased in ARDS — ventilated alveoli lack perfusion due to microvascular obstruction, while perfused alveoli lack ventilation due to flooding, yielding both V/Q mismatch and true shunt. — Murray & Nadel's
Biotrauma and Ventilator-Induced Lung Injury (VILI)
Mechanical ventilation itself can perpetuate ARDS through biotrauma:
- High tidal volumes overstretch the relatively small population of aerated alveoli (the "baby lung"), releasing cytokines (IL-6, IL-8, TNF-α) locally
- These cytokines translocate into the systemic circulation, driving multiorgan failure
- This is why most ARDS deaths are caused by sepsis and multiorgan failure, not by refractory hypoxemia per se — Murray & Nadel's
Summary Cascade
Trigger (sepsis, aspiration, trauma, etc.)
↓
Alveolar macrophage activation → proinflammatory cytokines (IL-1β, TNF-α, IL-8)
↓
Neutrophil recruitment → ROS + proteases + PAF
↓
Endothelial + epithelial barrier disruption
↓
Protein-rich exudate floods alveoli
↓
Surfactant dysfunction → alveolar collapse
↓
Hyaline membrane formation (DAD)
↓
Severe V/Q mismatch + shunt → refractory hypoxemia
↓
Pulmonary hypertension + dead space ventilation
↓
(Persistent) → fibroproliferation and fibrosis
Key point: ARDS is ultimately a dysregulated, amplified inflammatory response that destroys the alveolar-capillary barrier. The injury is not self-limited — ongoing cytokine release, neutrophil activation, and (if injurious ventilation is used) mechanical stretch perpetuate the cycle until either resolution or fatal multiorgan failure occurs.
— Murray & Nadel's Textbook of Respiratory Medicine; Goldman-Cecil Medicine